These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16198248)

  • 1. Prognostic value of the QRS duration in patients with heart failure: a subgroup analysis from 24 centers of Val-HeFT.
    Hofmann M; Bauer R; Handrock R; Weidinger G; Goedel-Meinen L
    J Card Fail; 2005 Sep; 11(7):523-8. PubMed ID: 16198248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value and temporal behavior of the planar QRS-T angle in patients with nonischemic cardiomyopathy.
    Pavri BB; Hillis MB; Subacius H; Brumberg GE; Schaechter A; Levine JH; Kadish A;
    Circulation; 2008 Jun; 117(25):3181-6. PubMed ID: 18574059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy.
    Iler MA; Hu T; Ayyagari S; Callahan TD; Civello KC; Thal SG; Wilkoff BL; Chung MK
    Am J Cardiol; 2008 Feb; 101(3):359-63. PubMed ID: 18237600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure.
    Davis DR; Krahn AD; Tang AS; Lemery R; Green MS; Gollob M; Yee R; Skanes AC; Klein GJ; Birnie DH
    Can J Cardiol; 2005 Apr; 21(5):413-7. PubMed ID: 15861258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic importance of change in QRS duration over time associated with left ventricular dysfunction in patients with congestive heart failure: the DIAMOND study.
    Fosbøl EL; Seibaek M; Brendorp B; Torp-Pedersen C; Køber L;
    J Card Fail; 2008 Dec; 14(10):850-5. PubMed ID: 19041049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower body mass index and atrial fibrillation as independent predictors for mortality in patients with implantable cardioverter defibrillator.
    Schernthaner C; Pichler M; Strohmer B
    Croat Med J; 2007 Feb; 48(1):59-67. PubMed ID: 17309140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged paced QRS duration as a predictor for congestive heart failure in patients with right ventricular apical pacing.
    Miyoshi F; Kobayashi Y; Itou H; Onuki T; Matsuyama T; Watanabe N; Liu C; Kawamura M; Asano T; Miyata A; Nakagawa H; Tanno K; Baba T; Katagiri T
    Pacing Clin Electrophysiol; 2005 Nov; 28(11):1182-8. PubMed ID: 16359284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification by T-wave morphology for cardiovascular mortality in patients with systolic heart failure.
    Huang HC; Lin LY; Yu HY; Ho YL
    Europace; 2009 Nov; 11(11):1522-8. PubMed ID: 19819880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical dyssynchrony assessed by tissue Doppler imaging is a powerful predictor of mortality in congestive heart failure with normal QRS duration.
    Cho GY; Song JK; Park WJ; Han SW; Choi SH; Doo YC; Oh DJ; Lee Y
    J Am Coll Cardiol; 2005 Dec; 46(12):2237-43. PubMed ID: 16360052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure after myocardial revascularization: risk markers.
    Biffi M; Bertini M; Boriani G; Martignani C; Branzi A
    Int J Cardiol; 2005 Oct; 105(1):11-4. PubMed ID: 16207539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
    Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database).
    Baldasseroni S; Gentile A; Gorini M; Marchionni N; Marini M; Masotti G; Porcu M; Maggioni AP;
    Ital Heart J; 2003 Sep; 4(9):607-13. PubMed ID: 14635378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of 6-minute walk corridor testing in women with mild to moderate heart failure.
    Rostagno C; Galanti G; Romano M; Chiostri G; Gensini GF
    Ital Heart J; 2002 Feb; 3(2):109-13. PubMed ID: 11926008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitral effective regurgitant orifice area versus left ventricular ejection fraction as prognostic indicators in patients with dilated cardiomyopathy and heart failure.
    Venturi F; Gianfaldoni ML; Melina G; Cecchi A; Petix NR; Monopoli A; Taiti A; Mazzoni V; Fantini F
    Ital Heart J; 2004 Oct; 5(10):755-61. PubMed ID: 15626272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.